Spectrophotometric Determination of Lead - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Spectrophotometric Determination of Lead
The authors developed a reliable spectrophotometric method for determining and measuring trace amounts of lead in various samples.

Pharmaceutical Technology

Table II: Comparison of analytical results of lead from UV–vis and ICP-MS methods (μg/g).
Comparison with ICP-MS results. Analytical results obtained with the UV–vis method have been validated by comparison with those acquired with a well-established ICP-MS method from a second laboratory. Table II provides method validation results for three different samples. Comparing the lead results obtained from the ICP-MS and from our UV–vis method, we can conclude that the UV–vis method is reliable and accurate.

Table III: Lead analytical results of some common samples (n = 3).
Lead analysis results. Using the UV–vis method described above, lead in several samples and at various levels has been successfully determined. Each sample was analyzed in triplicate and the average was reported. Table III lists analysis results of lead in some agricultural, food, and raw dietary supplement materials.

In all the samples listed in Table III, 2.0 μg of standard lead were always spiked for quality assurance. The accepted recovery result at our R&D department is set at 1.8–3.0 μg (90– 150% of the spiked lead). For all the samples, the percentage recoveries always fall in the range of 90–120%, and none are out of the accepted range.

Based on the lead analytical and recovery test results, the procedure described previously is effective for all materials included in the study. For most of the samples, the digestion time is <1 h. For some complicated dietary supplements, which might either contain certain compounds with high molecular weights or a mixture of organic and minerals ingredients, the digestion time may take as long as 2 h. In comparison, to digest this type of sample could take as long as 8 h, or even a couple days, if using the USP method (24).

The last two samples in Table III, hydrox 6% FD and olive extract, are samples that would be extremely difficult to digest if using the USP method. For such samples, repeated treatment with H2SO4–HNO3 or H2SO4–H2O2 would dramatically shorten the digestion time, usually by 2 h. For salt samples of alkaline earth metals, such as dicalcium phosphate, the USP digestion method does not work (24). Dicalcium phosphate contains ~29% calcium and 70% phosphate. If concentrated H2SO4 is used for the digestion, then a heavy precipitation is formed at pH adjustment (step 7). Mere HNO3 can also dissolve the sample, but if not enough masking reagent is used, then the calcium phosphate also will precipitate out when ammonium hydroxide is added to adjust the pH. In both cases, the precipitation makes it impossible to separate the lead from the sample solution. After trying different approaches and various masking reagents, we found the best way to avoid this problem was to:

  • Use smaller amount of samples (e.g., 2 g instead of 5–10 g) (step 1)
  • Add 30 mL of ammonium citrate as masking reagent instead of 5 mL (step 6)
  • Stir the sample solution while slowly adding ammonium hydroxide to adjust the pH (step 7).

Following all other procedures as stated previously, trace amounts of lead in the salts of alkaline earth metals was successfully determined (see Table I).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here